首页> 外文期刊>Therapeutic advances in urology. >Regenerative technology to restore and preserve erectile function in men following prostate cancer treatment: evidence for penile rehabilitation in the context of prostate cancer survivorship
【24h】

Regenerative technology to restore and preserve erectile function in men following prostate cancer treatment: evidence for penile rehabilitation in the context of prostate cancer survivorship

机译:前列腺癌治疗后男性的再生技术恢复和保留勃起功能:在前列腺癌生存中的阴茎康复证据

获取原文
       

摘要

Introduction: Erectile dysfunction (ED) following prostate cancer treatment is not uncommon and penile rehabilitation is considered the standard of care in prostate cancer survivorship (PCS), where both patient and his partner desire to maintain and/or recover pre-treatment erectile function (EF). There is a clinical interest in the role of regenerative therapy to restore EF, since existing ED treatments do not always achieve adequate results. Aim: To review regenerative therapies for the treatment of ED in the context of PCS. Materials and Methods: A review of the existing PubMed literature on low-intensity extracorporeal shockwave therapy (LIESWT), stem cell therapy (SCT), platelet-rich plasma (PRP), gene therapy, and nerve graft/neurorrhaphy in the treatment of ED and penile rehabilitation, was undertaken. Results: IESWT promotes neovascularization and neuroprotection in men with ED. While several systematic reviews and meta-analyses showed positive benefits, there is limited published clinical data in men following radical prostatectomy. Cellular-based technology such as SCT and PRP promotes cellular proliferation and the secretion of various growth factors to repair damaged tissues, especially in preclinical studies. However, longer-term clinical outcomes and concerns regarding bioethical and regulatory frameworks need to be addressed. Data on gene therapy in post-prostatectomy ED men are lacking; further clinical studies are required to investigate the optimal use of growth factors and the safest vector delivery system. Conceptually interpositional cavernous nerve grafting and penile re-innervation technique using a somatic-to-autonomic neurorrhaphy are attractive, but issues relating to surgical technique and potential for neural ‘regeneration’ are questionable. Conclusion: In contrast to the existing treatment regime, regenerative ED technology aspires to promote endothelial revascularization and neuro-regeneration. Nevertheless, there remain considerable issues related to these regenerative technologies and techniques, with limited data on longer-term efficacy and safety records. Further research is necessary to define the role of these alternative therapies in the treatment of ED in the context of penile rehabilitation and PCS.
机译:介绍:前列腺癌治疗后的勃起功能障碍(ED)并不罕见,阴茎康复被认为是前列腺癌生存(PC)的护理标准,其中患者和他的伴侣维持和/或恢复预治疗前勃起功能( EF)。由于现有的ED治疗并不总是达到充分的结果,因此对再生治疗的作用存在临床兴趣。目的:审查在PC背景下审查ed的再生疗法。材料和方法:对低强度体外冲击症治疗(LiEWT),干细胞治疗(SCT),富含血小板血浆(PRP),基因治疗和神经移植/神经移植/神经腐败的审查和阴茎康复,正在进行中。结果:IESWT促进了ED男性的新生血管和神经保护。虽然几种系统评价和荟萃分析表现出积极的益处,但在自由基前列腺切除术后,男性临床数据有限。基于细胞的技术,如SCT和PRP促进细胞增殖和各种生长因子的分泌,以修复受损组织,特别是在临床前研究。但是,需要解决长期临床结果和关于生物和监管框架的担忧。缺乏前列腺切除术治疗的基因治疗的数据;需要进一步的临床研究来研究生长因子和最安全的载体输送系统的最佳使用。概念上介入的海绵体神经移植和使用躯体对自主神经腐败的阴茎重新支配技术是有吸引力的,但与手术技术有关的问题和神经“再生的可能性”是值得怀疑的。结论:与现有的治疗制度相比,再生ED技术致力于促进内皮血运重建和神经再生。然而,与这些再生技术和技术有关的相当大,数据有限的数据有限的疗效和安全记录。进一步的研究是必要的,以确定这些替代疗法在阴茎康复和PC的背景下的eD治疗的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号